SCNI 주가 차트
SCNI 수입
Scinai Immunotherapeutics Ltd
$0.28
-1.71%
$0
종가: Jun 23, 16:00:00 GMT-4
$0.3
4.89%
$0.01
애프터마켓: Jun 23, 20:00:00 GMT-4
뒤로
Scinai Immunotherapeutics Ltd (SCNI) 수입
최신 수익 결과: Q4 '23
보고됨: 2024-05-15
역사적 수익
분기별
연간
EPS
수익
Earnings FAQ
SCNI의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Scinai Immunotherapeutics Ltd SCNI의 지난 분기 매출 실적은 어땠나요?
Scinai Immunotherapeutics Ltd의 매출 추정치는 얼마인가요?
Scinai Immunotherapeutics Ltd의 수익 품질 점수는 얼마인가요?
Scinai Immunotherapeutics Ltd는 언제 수익을 보고하나요?
Scinai Immunotherapeutics Ltd의 예상 수익은 얼마인가요?
Scinai Immunotherapeutics Ltd은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.291
시가
$0.28
일일 범위
$0.2664 - $0.3063
52주 범위
$0.3 - $3.48
거래량
--
평균 거래량
2.3M
배당수익률
--
EPS(TTM)
-0.00
시가총액
$1.1M
SCNI란 무엇인가요?
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The firm's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
